Laboratorios Richmond SACIF - Asset Resilience Ratio

Latest as of September 2025: 0.22%

Laboratorios Richmond SACIF (RICH) has an Asset Resilience Ratio of 0.22% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Laboratorios Richmond SACIF for a breakdown of total debt and financial obligations.

Liquid Assets

AR$778.82 Million

≈ $563.56K USD Cash + Short-term Investments

Total Assets

AR$354.98 Billion

≈ $256.86 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2024)

This chart shows how Laboratorios Richmond SACIF's Asset Resilience Ratio has changed over time. See Laboratorios Richmond SACIF (RICH) net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Laboratorios Richmond SACIF's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Laboratorios Richmond SACIF (RICH) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AR$0.00	0%
Short-term Investments	AR$778.82 Million	0.22%
Total Liquid Assets	AR$778.82 Million	0.22%

Asset Resilience Insights

Limited Liquidity: Laboratorios Richmond SACIF maintains only 0.22% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Laboratorios Richmond SACIF Industry Peers by Asset Resilience Ratio

Compare Laboratorios Richmond SACIF's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Yabao Pharmaceutical Group Co Ltd SHG:600351	Drug Manufacturers - Specialty & Generic	0.27%
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	6.43%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	6.40%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%

Annual Asset Resilience Ratio for Laboratorios Richmond SACIF (2011–2024)

The table below shows the annual Asset Resilience Ratio data for Laboratorios Richmond SACIF.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	1.13%	AR$2.95 Billion ≈ $2.13 Million	AR$260.15 Billion ≈ $188.25 Million	+1.01pp
2023-12-31	0.12%	AR$404.16 Million ≈ $292.45K	AR$337.32 Billion ≈ $244.09 Million	-3.40pp
2022-12-31	3.52%	AR$1.43 Billion ≈ $1.04 Million	AR$40.72 Billion ≈ $29.47 Million	-6.96pp
2021-12-31	10.48%	AR$2.69 Billion ≈ $1.95 Million	AR$25.69 Billion ≈ $18.59 Million	+6.23pp
2020-12-31	4.25%	AR$345.71 Million ≈ $250.16K	AR$8.13 Billion ≈ $5.89 Million	+4.22pp
2019-12-31	0.03%	AR$1.72 Million ≈ $1.24K	AR$5.13 Billion ≈ $3.72 Million	+0.02pp
2018-12-31	0.02%	AR$480.78K ≈ $347.90	AR$2.71 Billion ≈ $1.96 Million	-0.15pp
2017-12-31	0.16%	AR$2.56 Million ≈ $1.85K	AR$1.55 Billion ≈ $1.12 Million	-0.73pp
2016-12-31	0.89%	AR$7.67 Million ≈ $5.55K	AR$861.13 Million ≈ $623.12K	+0.80pp
2015-12-31	0.09%	AR$494.37K ≈ $357.73	AR$532.83 Million ≈ $385.56K	-0.30pp
2014-12-31	0.39%	AR$1.51 Million ≈ $1.09K	AR$385.66 Million ≈ $279.06K	-0.18pp
2013-12-31	0.58%	AR$1.66 Million ≈ $1.20K	AR$287.37 Million ≈ $207.94K	-0.90pp
2012-12-31	1.47%	AR$3.99 Million ≈ $2.89K	AR$270.95 Million ≈ $196.06K	+1.43pp
2011-12-31	0.04%	AR$60.00K ≈ $43.42	AR$159.03 Million ≈ $115.07K	--

pp = percentage points

About Laboratorios Richmond SACIF

BA:RICH Argentina Drug Manufacturers - Specialty & Generic

Market Cap

$79.02 Million

AR$109.20 Billion ARS

Market Cap Rank

#20097 Global

#55 in Argentina

Share Price

AR$1640.00

Change (1 day)

+3.14%

52-Week Range

AR$970.00 - AR$2165.00

All Time High

AR$2165.00